{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"}],"units":"Participants"}],"description":"Here is the number of participants with adverse events. For the detailed list of adverse events, see the adverse event module.","groups":[{"description":"Subjects will receive a unmanipulated donor lymphocyte infusion (DLI) on Day 1 after radiation (single, 8-Gy fraction to the maximum number of lesions).","id":"OG000","title":"Donor Lymphocyte Infusion/Radiation"},{"description":"Subjects will receive radiation (single, 8-Gy fraction to the maximum number of lesions).","id":"OG001","title":"Radiation/No Donor Lymphocyte Infusion"},{"description":"Subjects will receive a unmanipulated donor lymphocyte infusion (DLI) on Day 0.","id":"OG002","title":"Donor Lymphocyte Infusion - Control"},{"description":"Healthy subjects who donated lymphocytes for infusion on a treatment Arm.","id":"OG003","title":"Donor Lymphocyte Infusion - Donor"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Date treatment consent signed to date off study, approximately 36 months.","title":"Number of Participants With Adverse Events","type":"SECONDARY","unitOfMeasure":"Participants"}